WallStreetZenWallStreetZen

NASDAQ: RNTX
Rein Therapeutics Inc Stock Ownership - Who owns Rein Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rein Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Voss Capital LP10% Owner2025-11-14104,183$1.23
$127.62kBuy
Voss Capital LP10% Owner2025-10-28178,392$1.39
$247.96kBuy
Voss Capital LP10% Owner2025-10-2792,642$1.37
$126.92kBuy
Voss Capital LP10% Owner2025-10-274,840$1.37
$6.63kBuy
Voss Capital LP10% Owner2025-10-2430,176$1.39
$41.94kBuy

1 of 1

RNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNTX insiders and whales buy or sell their stock.

RNTX Shareholders

What type of owners hold Rein Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter63.19%16,609,449$17.77MInsider
Voss Capital LP10.14%2,666,532$2.85MInstitution
Reinhard J. Ambros9.70%2,549,982$2.73MInsider
Voss Capital LP9.29%2,442,649$2.61MInsider
Novartis Bioventures Ltd7.91%2,079,394$2.22MInsider
Of Texastexas Am Investment Managment Co University6.89%1,810,457$1.94MInsider
University Of Texastexas Am Investment Management Co6.64%1,746,549$1.87MInsider
Bios Capital Management LP6.43%1,690,751$1.81MInstitution
Brian M. Gallagher Jr.5.45%1,431,519$1.53MInsider
Vanguard Group Inc4.44%1,168,407$1.25MInstitution

1 of 3

RNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNTX18.96%81.04%Net BuyingNet Buying
GLTO2.48%97.52%Net Selling
HOWL32.70%67.30%Net SellingNet Selling
RNXT19.45%11.57%Net BuyingNet Buying
EVAX0.42%0.00%
View Top Biotech Stocks

Rein Therapeutics Stock Ownership FAQ

Who owns Rein Therapeutics?

Rein Therapeutics (NASDAQ: RNTX) is owned by 32.30% institutional shareholders, 138.07% Rein Therapeutics insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Rein Therapeutics shareholder, owning 16.61M shares representing 63.19% of the company. Muneer A. Satter's Rein Therapeutics shares are currently valued at $19.27M.

If you're new to stock investing, here's how to buy Rein Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.